Lifecore Biomedical, Inc. LFCR Cash Flow Statement
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | ||
|---|---|---|---|---|---|---|
| -$38.72M— | —— | —— | —— | —— | ||
| $8.03M-1.2% | $8.13M+0.9% | $8.06M+3.6% | $7.78M-2.2% | $7.95M-7.6% | ||
| $10.16M+2.2% | $9.94M+11.9% | $8.88M+25.3% | $7.09M+14.3% | $6.2M+14.4% | ||
| —— | $3.16M+480% | $545K-93.2% | $7.97M+3,002% | $257K+102% | ||
| $13.42M-4.4% | $14.03M-6.1% | $14.94M-10.9% | $16.76M-8.9% | $18.4M— | ||
| -$6.42M+8.8% | -$7.03M+52.9% | -$14.94M+10.9% | -$16.76M+8.9% | -$18.4M+15.8% | ||
| —— | —— | —— | $29.91M— | $0-100% | ||
| $6.83M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Lifecore Biomedical, Inc. generate?
- Lifecore Biomedical, Inc. (LFCR) generated $1.5M in operating cash flow over the trailing twelve months.
- What is Lifecore Biomedical, Inc.'s free cash flow?
- After $10.4M of capital expenditures, Lifecore Biomedical, Inc.'s free cash flow was -$9.2M over the trailing twelve months, up 67.2% year over year.
- Where does Lifecore Biomedical, Inc.'s cash flow data come from?
- Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
